Published in Scientific Works. Series C. Veterinary Medicine, Vol. LXI
Written by Dan CRÎNGANU, Rǎzvan NEGREANU, Raluca NEGREANU
Non Hodgkin malignant lymphoma ( NHML ) is not a simple malignant disease , having a varied symptomatic polymorphism based on neoplastic solid proliferation (lymphoma ) or liquid proliferation (leukemia)of the lymphocytes (mainly B ) in lymphoid tissues ( lymphnodes , spleen and thymus ) or in other tissues rich in lymphoid structures ( intestine , liver and tonsils) The natural clinical evolution (untreated) of the malignant lymphoma is multistage, advancing rapidly through progression from the first affected lymphnodes to the neighboring lymphnodes and successive invasion of the organs. NHL therapy in humans is well studied and standardized for each type of lymphoma but according to the clinical stage and the health condition of the patient. The use of combination therapy (cytostatic multi-agent therapy while ecosanitzing the biotope of the pacient) and the epidemiological investigation to identify common oncogenic factors involved in the etiopathogenesis issues are some of the objectives pursued. The results obtained by associating multimodal therapy o the patient simultaneously with ecosanitizing the living environment by avoiding or diminishing oncogenic factors could be extrapolated in the treatement of the human cancers. Identification of common oncogenic factors in human and pets habitat is a major goal, knowing that it is easier to prevent than to treat.
[Read full article] [Citation]
